Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.
Published November 25, 2020 · Recall initiated: November 11, 2020
Summary
FDA records drug Class III recall D-0100-2021, published November 25, 2020 and initiated November 11, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 12,088 cartons; Lot: Lot Number: 1351104, Exp 08/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: High out-of-specification assay results were obtained during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if TESTOSTERONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TESTOSTERONE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Product was distributed Nationwide in the USA.
- Lot
- Lot Number: 1351104, Exp 08/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, ManufacturedDecember 10, 2025
- FDATestosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc.,April 2, 2025
- FDATestosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides PharmaApril 2, 2025
- FDATestosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc.August 28, 2024
- FDAHomeopathic Energy Catalyst, 1 fl oz (30 mL) Distributed by: Deseret Biologicals, Inc. 469 W. Parkland DriveNovember 25, 2020
- FDASodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as aNovember 25, 2020
Questions about this recall
Was Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054. recalled?
Yes. FDA published recall D-0100-2021 on November 25, 2020. Reported hazard: Superpotent Drug: High out-of-specification assay results were obtained during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TESTOSTERONE.